Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm, Residual × Calcium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pain 1 Neoplasm, Residual 1 Multiple Myeloma 1 Dwarfism, Pituitary 1 Disease Progression 1 Breast Neoplasms 1 Bone Diseases, Metabolic 1

Interventions

blinatumomab 3 Cytarabine 2 Cyclophosphamide 2 Azacitidine 2 venetoclax 1 sabatolimab 1 ruxolitinib 1 pulrodemstat besilate 1 peginterferon alfa-2a 1 nilotinib 1 fludarabine 1 daratumumab 1 Zoledronic Acid 1 Vitamin D 1 Methotrexate 1 Imatinib Mesylate 1 GNKG168 1 Dasatinib 1 Clofarabine 1 Celecoxib 1 Calcium 1 CD3 Complex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00172068 2009-12-23

MRD-1

Novartis

Phase 2 Terminated

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡